FibroGen
FGEN
#9906
Rank
NZ$68.51 M
Marketcap
NZ$16.94
Share price
7.65%
Change (1 day)
-38.80%
Change (1 year)

Market capitalization of FibroGen (FGEN)

Market cap: NZ$68.51 Million

As of January 2026 FibroGen has a market cap of NZ$68.51 Million. This makes FibroGen the world's 9906th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of FibroGen from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$68.51 M10.21%
2025NZ$62.16 M-40.01%
2024NZ$0.10 B-24.81%
2023NZ$0.13 B-94.19%
2022NZ$2.37 B23.88%
2021NZ$1.91 B-59.09%
2020NZ$4.67 B-16.2%
2019NZ$5.58 B-5.29%
2018NZ$5.89 B7.44%
2017NZ$5.48 B181.15%
2016NZ$1.95 B-29.29%
2015NZ$2.75 B33.94%
2014NZ$2.06 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Illumina
ILMN
NZ$37.81 B 55,097.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$19.06 B 27,729.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Accelerate Diagnostics
AXDX
NZ$1.49 M-97.81%๐Ÿ‡บ๐Ÿ‡ธ USA